Teleflex to separate into 2 public firms
Shares of Teleflex Inc. slipped 4.57% to $132.75 Friday, on what proved to be an all-around great trading session for the ...
Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...
Truist lowered the firm’s price target on Teleflex (TFX) to $149 from $200 and keeps a Hold rating on the shares. The firm says the company’s ...
Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...
Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...
Teleflex (TFX – Research Report) received a Hold rating and price target from Raymond James analyst Jayson Bedford today. The company’s ...
Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...
Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...
Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings tomorrow before market open. Here’s what to look ...
Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback